MedTrace Logo

Peritoneal Carcinomatosis Extent Evaluation: Radiologic, Laparoscopic and Pathologic.

NCT03798132 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2019-01-09

No results posted yet for this study

Summary

pathologically proved ovarian cancer patients that underwent contrast enhanced abdomino-pelvic CT and diagnostic laparoscopy before cytoreductive surgery (CRS) will be included in the study. Calculation of PCI (peritoneal cancer index) using Sugarbaker's method, peritoneal carcinomatosis extent will be categorized into low, moderate and large. Agreement in general and in each category between CT, laparoscopy, surgery and pathology will be assessed using kappa agreement.

Conditions

  • Peritoneal Carcinomatosis

Interventions

DIAGNOSTIC_TEST

laparoscopy

evaluation of peritoneal carcinomatosis by laparoscopy

Sponsors & Collaborators

  • Shimaa Abdalla Ahmed

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2019-06-11
Completion
2020-12-31
FDA Device
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03798132 on ClinicalTrials.gov